VISENTIN, Sonia
Dettaglio
VISENTIN, Sonia
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Pubblicazioni
Risultati 1 - 20 di 130 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors | 2016 | Giordano, S; Morosi, L; Veglianese, P; Licandro, S A; Frapolli, R; Zucchetti, M; Cappelletti, G; Falciola, L; Pifferi, V; Visentin, S; D'Incalci, M; Davoli, E |
2 | A KINETIC STUDY BY STOPPED FLOW OF THE INTERACTION BETWEEN POTENTIAL PHOTOSENSITIZERS AND ALBUMIN | 2014 | Sonja Visentin ; Nadia Barbero ; Guido Viscardi |
3 | A kinetic study of the interaction between potential photosensitizers and albumin | 2013 | Sonja Visentin ; Nadia Barbero; Guido Viscardi ; Giulia Caron ; Giuseppe Ermondi |
4 | A New Synthetic Approach to Substituted β-Carboline Systems | 1999 | GIUSEPPE ERMONDI; SONJA VISENTIN; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO |
5 | A study of the interaction between mucin and pristine or functionalized carbon nanotubes | 2013 | Sonja Visentin; Nadia Barbero; Luca Bonadini; Marco Marenchino; Simona Oliaro Bosso; Guido Viscardi |
6 | Advanced glycation end products (AGEs) as pathology biomarkers: microwave assisted synthesis and biological quantitative analysis by LC-FTMS | 2011 | C. Medana; S. Visentin; F. Dal Bello; V. Giancotti; R. Mastrocola ; M. Aragno; C. Baiocchi |
7 | AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation | 2012 | Guglielmotto M; Aragno M; Tamagno E; Vercellinatto I; Visentin S; Medana C; Catalano MG; Smith MA; Perry G; Danni O; Boccuzzi G; Tabaton M. |
8 | Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery | 2017 | Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S |
9 | Application of 3D Mass Spectrometry Imaging to TKIs | 2017 | Morosi, L.; Giordano, S.; Falcetta, F.; Frapolli, R.; Licandro, S. A.; Matteo, C.; Zucchetti, M.; Ubezio, P.; Erba, E.; Visentin, S.; D'Incalci, M.; Davoli, E. |
10 | Application of in silico classical drug discovery tools for peptide research | 2013 | Ermondi, Giuseppe; Esposito, Roberto; Visconti, Alessia; Visentin, Sonja; Vallaro, Maura; Rinaldi, Laura; Caron, Giulia |
11 | APPLICATION OF IN-SILICO "CLASSICAL" DRUG DISCOVERY TOOLS TO PEPTIDE RESEARCH | 2013 | G. Ermondi; R. Esposito; A. Visconti; S. Visentin; M. Vallaro; L. Rinaldi; G. Caron |
12 | Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists | 2000 | SONJA VISENTIN; GIUSEPPE ERMONDI; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO |
13 | Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists | 2000 | S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco |
14 | Atmospheric pressure plasma as a green tool for surface modification and functionalization | 2011 | N. Barbero; L. Bonandini; C. Barolo; P. Quagliotto; S. Visentin; G. Viscardi |
15 | A biosimilar mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies | 2018 | Cosmin Butnarasu, Maura Vallaro, Daniela Pacheco, Paola Petrini, Livia Visai, Sonja Visentin |
16 | Blended-learning for courses in Pharmaceutical Analysis | 2011 | Giulia Caron; Sonja Visentin; Giuseppe Ermondi |
17 | Blended-learning for courses in Pharmaceutical Analysis. Part 2 | 2013 | Visentin S; Ermondi G; Vallaro M; Scalet G; Caron G |
18 | Carbon nanodots as delivery system for Squaraines: an in vitro study to investigate their Photodynamic activity | 2019 | Cosmin Butnarasu, Edoardo Di Gioia, Giorgia Delsoglio, Giorgia Chinigò, Alessandra Fiorio Pla, Nadia Barbero, Sonja Visentin |
19 | Carbon nanodots as nanocarrier for Squaraines: an in vitro evaluation of their Photodynamic activity | 2021 | C. Butnarasu, C. Pontremoli, M.J. Moràn Plata, E. Sansone, G. Chinigò, A. Fiorio Pla, N. Barbero, S. Visentin |
20 | Carbon nanotubes for targeted drug delivery | 2009 | Chiara Biale; Valentina Mussi; Ugo Valbusa; Sonja Visentin; Guido Viscardi; Nadia Barbero; Nicoletta Pedemonte; Luis Galietta |